NDC product
Tranexamic Acid
NDC 23155-166 · Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.
Key facts
| Product NDC | 23155-166 |
|---|---|
| Proprietary name | Tranexamic Acid |
| Nonproprietary name | Tranexamic Acid |
| Substances | TRANEXAMIC ACID |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA203521 |
| Pharmacologic classes | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| Marketing start | Aug 13, 2014 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: